Trials / Completed
CompletedNCT01514903
Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra® Conventional Oral Tablet in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a single dose open-label comparative pharmacokinetic study to assess the pharmacokinetic characteristics of sildenafil between HIP0908 (chewable tablet) and Viagra (tablet) in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HIP0908 | SINGLE DOSE , CROSS OVER |
| DRUG | viagra | single dose, cross over |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2012-01-23
- Last updated
- 2016-10-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01514903. Inclusion in this directory is not an endorsement.